Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

31.13
Delayed Data
As of Jul 22
 +0.60 / +1.97%
Today’s Change
26.97
Today|||52-Week Range
34.88
-8.31%
Year-to-Date
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
AstraZeneca (AZN) Is Today's Storm The Castle Stock
Jul 20 / TheStreet.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Relypsa Finally Finds Buyer, But Potential Seen For Rival Bid
Jul 21 / TheStreet.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
Heavy Volume And Pre-Market Movement For AstraZeneca (AZN)
Jul 21 / TheStreet.com - Paid Partner Content
Is This Gilead Sciences' Most Underappreciated Drug Candidate?
Jul 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close30.53
Today’s open30.44
Day’s range30.40 - 31.23
Volume12,323,120
Average volume (3 months)4,738,041
Market cap$77.2B
Dividend yield4.50%
Data as of 4:03pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-7.08%
Earnings growth (next 5 years)+1.40%
Revenue growth (last year)-5.11%
P/E ratio27.1
Price/Sales3.48
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.07+0.07%
LLYEli Lilly and Co+1.19+1.48%
ABTAbbott Laboratories+0.13+0.30%
SHPGShire+0.03+0.02%
Data as of 4:04pm ET, 07/22/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.48
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs